Hybridoma cell lines and monoclonal antibodies to theophylline
US4524025A · kind A · utility
14Cited by
5References
3Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Aug 9, 1982 |
| Grant date | Jun 18, 1985 |
| Priority date | — |
| Expiry date | Aug 9, 2002 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/809
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Monoclonal antibodies to theophylline having 5% or less cross-reactivity with caffeine and the continuous hybrid monoclonal cell lines for their production are provided. These antibodies are useful in a particle-enhanced turbidimetric inhibition immunoassay for theophylline.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.